About the Authors

Maria Tropeano

maria.tropeano@kcl.ac.uk (MT); collier_david_andrew@lilly.com (DAC)

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

Joo Wook Ahn

Affiliation Department of Cytogenetics, Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom

Richard J. B. Dobson

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

Gerome Breen

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

James Rucker

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

Abhishek Dixit

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

Deb K. Pal

Affiliation Department of Clinical Neuroscience, Institute of Psychiatry, King’s College London, London, United Kingdom

Peter McGuffin

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

Anne Farmer

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

Peter S. White

Affiliations Center for Biomedical Informatics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

Joris Andrieux

Affiliation Institut de Génétique Médicale, CHRU de Lille, Lille, France

Evangelos Vassos

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

Caroline Mackie Ogilvie

Affiliation Department of Cytogenetics, Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom

Sarah Curran

Contributed equally to this work with: Sarah Curran, David A Collier

Affiliation MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom

David A Collier

Contributed equally to this work with: Sarah Curran, David A Collier

maria.tropeano@kcl.ac.uk (MT); collier_david_andrew@lilly.com (DAC)

Affiliations MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, United Kingdom, Discovery Neuroscience Research, Eli Lilly and Company Ltd, Lilly Research Laboratories, Erl Wood Manor, Windlesham, Surrey, United Kingdom

Competing Interests

The authors have read the journal's policy and have the following conflicts: DAC is a full time employee of Eli Lilly & Co. Ltd. AF and PMG have received consultancy fees and honoraria for participating in expert panels for pharmaceutical companies including GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: MT JWA RJBD CMO SC DAC. Performed the experiments: MT JWA GB JR CMO SC DAC. Analyzed the data: MT JWA EV CMO DAC. Contributed reagents/materials/analysis tools: AD DKP PM AF PSW JA. Wrote the paper: MT.